Abstract Plasmodium falciparum glutathione reductase (PfGR) has emerged as a drug target against tropical malaria. Here we report the expression of PfGR in Escherichia coli SG5(DE3) and isolation procedures for this protein. Recombinant PfGR does not differ from the authentic enzyme in its enzymic properties, the turnover number being 9900 min 3I . The dimeric flavoenzyme exhibits redox-dependent absorption spectra; the single tryptophan residue (per 57.2 kDa subunit) is strongly fluorescent. PfGR can be inhibited by the antimalarial drug methylene blue at therapeutic concentrations; the K i for non-competitive inhibition is 6.4 W WM. The sensitivity to methylene blue is observed also at high ionic strength so that, by analogy to human GR, analysis of crystalline enzyme-drug complexes can be envisaged.
Introduction
The clinical manifestations of tropical malaria are caused by the multiplication and di¡erentiation of the protozoan parasite Plasmodium falciparum in human erythrocytes. Malarial parasites appear to be more sensitive to reactive oxygen species than their host cells [1] . Inherited or drug-induced de¢ciency of antioxidative erythrocyte enzymes such as glucose-6-phosphate dehydrogenase [2, 3] or glutathione reductase [4, 5] appear to protect from severe forms of falciparum malaria. Glutathione reductase (GR), a dimeric £avoenzyme, catalyses the reduction of glutathione disul¢de using NADPH as a source of reducing equivalents: GSSG+NADPH+H = 2GSH+NADP
. In the cytosol the enzyme maintains a [GSH]/[GSSG] ratio of v 100. Glutathione in its reduced form represents the most abundant intracellular non-protein thiol. It is involved in a broad range of functions such as protection of biomolecules from oxidative damage, detoxi¢ca-tion of xenobiotics, and regulation of enzyme activity [6^9] .
Both P. falciparum GR and human erythrocyte GR play crucial roles for the intraerythrocytic growth of the parasite. Human GR is a well characterized protein; the catalytic cycle as well as the binding mode of drugs and other ligands have been studied in great detail [4,6,7,10^12] . P. falciparum GR (PfGR) has recently come into focus as a drug target. The enzyme was puri¢ed from parasitized red blood cells but only in Wg quantities [13] . To promote structural and functional studies on this protein, the gene of PfGR was isolated [14] . As reported here, recombinant PfGR (rPfGR) was expressed, puri¢ed and characterized, in particular as a target of methylene blue. This antimalarial compound, the ¢rst chemotherapeutic agent to be successfully used in humans [15, 16] , is known to interfere with the glutathione metabolism of parasitized erythrocytes [17] .
Materials and methods

Materials and assay systems
E. coli SG5(DE3) was a kind gift of Dr. Sylke Mu ë ller, BernhardNocht-Institute, Hamburg. Authentic PfGR (5 Wg from 1 g erythrocytes containing P. falciparum FBRC schizonts) was isolated as previously reported [13] . Recombinant human GR was puri¢ed and assayed as described [12] . Expression vector pET22b+ was from Novagen, Tth DNA polymerase from Boehringer Mannheim, and restriction enzymes were from New England Biolabs. Superose 12 and 2P,5P-ADP-Sepharose were purchased from Pharmacia and NADPH, GSSG, and IPTG from Biomol. Methylene blue (Fluka) was used as a 10 mM stock solution in H P O. Vivaspin concentrator units were from Greiner.
Protein in crude fractions was estimated by absorbance measurements at 228.5 nm and 234.5 nm according to Ehresman et al. [18] . For puri¢ed PfGR in the E ox form, a solution of 1 mg/ml was found to have an absorbance of 0.205 at 461 nm and of 1.43 at 275 nm. These calibrations were performed by correlation with the absorbance coe¤cient of E ox which is 11.7 mM 3I cm 3I at 461 nm per 57.2 kDa subunit (see Section 2.5).
Construction of the expression vector pG11
The fragments of the PfGR gene present in the plasmid constructs pG1, pG2, pG3, and pG4 described in [14] were fused by consecutive ligation into vector pT7 Blue (Novagen), taking advantage of unique restriction sites for HincII, NheI, and SpeI in the ORF, to ¢nally obtain construct pTG1-4. The 5P-end was obtained by 5P-RACE-PCR on a Tth DNA polymerase-synthesized cDNA (T 6.1, see [14] ); the oligonucleotide primer G2 binds downstream the unique HincII site (ATCGATCCAACGTTGACACACGTTC), whereas primer SN5 (ACGTAGCATGCCATATGGTTTACGATTTAATTG-TAATTG) introduces SphI and NdeI restriction sites juxtaposed to the start codon. The PCR product was digested with SphI and HincII and ligated into pT1-4, resulting in the complete ORF of PfGR in the plasmid pTG1-5. To remove the 3P-non-translated region of the cDNA, pTG1-5 was digested with StyI and SacI and recircularized by ligation of the hybridized oligonucleotides TGATGGATGAAAT-GACTCGAGGAGCT and CACCCTCGAGTCATTTCATC, thereby introducing an XhoI site upstream the SacI site. From this construct, pTG, the complete ORF was excised by a NdeI-XhoI digest and inserted into plasmid pET22b+, resulting in pG11 which encodes the protein of 500 residues (N-terminal Met+499 residues [14] ) under the control of a T7 RNA polymerase promoter. The plasmid was then introduced into E. coli SG5(DE3), a GR-de¢cient strain transformed with phage DE3 to allow T7 DNA polymerase-dependent expression.
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Puri¢cation of recombinant PfGR
Plasmid-carrying SG5(DE3) cells were grown in Luria-Bertani medium containing 50 Wg/ml carbenicillin to an apparent OD THH nm s 0.5. PfGR expression was then induced by 1 mM IPTG. After 12 h at 25³C the cells were harvested by centrifugation. The resulting bacterial pellet (appr. 7 g) was resuspended in lysing solution (50 mM Tris-HCl, 150 mM NaCl, 10% glycerol, 0.03% Triton X-100, 1 mg/ml lysozyme, 10 WM phenylmethylsulfonyl £uoride, 10 Wg/ml DNase I, pH 7.5) and subjected to sonication.
After clearing centrifugation, the supernatant was saturated to 80% with ammonium sulfate and left for 12 h at 4³C. The resulting precipitate was collected by centrifugation, and the pellet was dialysed exhaustively at 4³C against 25 mM potassium phosphate, 1 mM EDTA, pH 7.0. The retentate was then applied to a 5 ml 2P,5P-ADP-Sepharose column equilibrated with the same bu¡er. This column was washed and eluted as described for authentic PfGR [13] . Fractions with PfGR activity were pooled, and 1 mM GSSG was added in order to oxidize the NADPH used for eluting the enzyme. The pool was then concentrated and washed with 25 mM potassium phosphate, 1 mM EDTA, pH 6.9, or 50 mM sodium phosphate, pH 6.9, respectively, using Vivaspin concentrator units. As judged by silver-stained SDS-PAGE the resulting protein was s 98% pure (data not shown).
In order to fully saturate PfGR with its prosthetic group FAD, 1 ml protein solution (E ox with an absorbance of 0.360 at V mxYvis = 461 nm in 50 mM sodium phosphate, pH 6.9) was titrated with 100 WM FAD in the same bu¡er. 0.5 Wl aliquots were removed after each FAD addition for measuring the enzyme activity. When more than 0.75 nmol FAD had been added the enzyme activity did not increase further and the spectrum of the solution indicated the presence of free FAD. It was concluded that the batch of puri¢ed enzyme contained 2.4% apoprotein, and FAD was supplemented to give a PfGR solution which contained 100 þ 0.3% holoenzyme, the absorbance at 461 nm being 0.369.
Steady state kinetics and inhibition studies
Glutathione reductase activity was assayed at 25³C with 100 WM NADPH and 1 mM GSSG in assay bu¡er (47 mM potassium phosphate, 200 mM KCl, 1 mM EDTA, pH 6.9) according to published procedures [19] . The enzyme-catalyzed conversion of NADPH to NADP was followed spectrophotometrically (O at 340 nm = 6.22 mM 3I cm 3I ). One enzyme unit is de¢ned as the GSSG-dependent oxidation of 1 Wmol NADPH per min.
The inhibitory e¡ect of methylene blue on recombinant PfGR, authentic PfGR [13] and human GR [12] was studied as follows. Methylene blue and NADPH were added ¢rst to the assay bu¡er and the decrease of absorbance (vA1/vt) was monitored for 1 min. This accounted for the spontaneous reaction of NADPH with methylene blue which was signi¢cant at drug concentrations above 10 WM. Subsequently GR (appr. 10 mU) was added and the ensuing vA2/vt was followed for another minute. vA2/vt was found not to di¡er appreciably from vA1/vt indicating that GR has negligible methylene blue reduction activity. The glutathione disul¢de reduction reaction was started with GSSG and yielded vA3/vt. After correction for dilution, the glutathione reductase activity was proportional to (vA3/min3 vA2/min). The possibility of irreversible inhibition was tested by incubating PfGR at 2 U/ml (170 nM) for 30 min at 4³C and 25³C with 10, 100 or 500 WM methylene blue, and then assaying aliquots for enzyme activity. These incubations were carried out at pH 6.9 and pH 7.4 in the presence and absence of 100 WM NADPH.
Absorbance and £uorescence measurements
The O-value at V mxYvis of recombinant PfGR in the E ox form was computed on the basis of the amount of FAD separated from the protein by incubation with 0.2% SDS in 50 mM sodium phosphate bu¡er, pH 6.9, for 60 min at 45³C in the dark [20] . From 1 ml holoenzyme with an absorbance of 0.369 at 461 nm (see Section 2.3) 31.5 nmol FAD was released. This corresponds to an O of 11.7 mM 3I cm 3I for the holoenzyme. When determining FAD we took into account that, in the presence of 0.2% SDS, free FAD has a millimolar absorbance coe¤cient of 11.4 mM 3I cm 3I at 448 nm and that 3% of the released FAD is thermally destroyed during the incubation at 45³C.
Absorption spectroscopy of PfGR under anaerobic conditions was carried out using the methods detailed for E. coli glutathione reductase [21] . After recording the spectrum of PfGR in oxidized form (E ox ; 9.5 nmol enzyme subunit in 1 ml 50 mM potassium phosphate, 2 mM EDTA, pH 7.45 at 25³C), the enzyme was converted to the EH P form using sodium borohydride (150 nmol dissolved in 2 ml 0.2 M NaOH) as a reductant. NaBH R hydrolysis (t IaP = 20 s at pH 7.45) did not interfere with the reduction of PfGR which was complete in less than 1 min. The spectra at pH 6.9 exhibited the same characteristics as at pH 7.45. However, a 60-fold excess of sodium borohydride had to be used because of the 7-fold higher hydrolysis rate at pH 6.9 [22] .
Fluorescence measurements were conducted according to Mulrooney [23] . For the emission spectra of FAD, both free and proteinbound, the excitation was set at 380 nm while the observed peak of relative £uorescence for both was at 540 nm. Tryptophan, both free and protein-bound, was excited at 295 nm; the emission peaks were at 330 nm and 340 nm, respectively. In addition to this blue shift [24] , the £uorescence of the enzyme's unique Trp residue was enhanced 2-fold when compared with the free amino acid.
Results and discussion
Expression and puri¢cation of rPfGR
Recently we have characterized the PfGR gene of the P. falciparum strain K1 (Thailand) [14] . As the gene carries two introns, RT-PCR on parasitic mRNA from erythrocytic stages was used to obtain the 5P-end of the open reading frame. Expecting a solid stem structure of the mRNA, Tth DNA polymerase was used as this enzyme exhibits reverse transcriptase activity at 65³C. By several cloning steps, the resulting PCR product and the inserts of pG1^pG4 were fused to gain the complete ORF of PfGR in plasmid pTG. Its insert was excised and ligated into vector pET22b+, and the resulting construct pG11 was transformed into the glutathione reductase-de¢cient E. coli strain SG5(DE3). The expressed protein, recombinant PfGR, was puri¢ed to homogeneity and demonstrated high enzymatic activity (Table 1) .
Characterization of recombinant PfGR
Systematic studies on a large malarial protein as a drug target are hampered by the following di¤culties. The authentic protein can be isolated only in small amounts from the parasite and tends to be contaminated with host cell proteins of similar function. Furthermore, recombinant parasite genes often resist functional expression in heterologous systems. As reported here, it was possible to obtain P. falciparum glutathione reductase in good yield, and its enzymic properties were found to be practically indistinguishable from those of the authentic enzyme. Physicochemical studies on rPfGR were conducted in comparison with the human host enzyme ( Table  2 ). The two enzymes had, for instance, comparable characteristics when subjected to gel ¢ltration on Superose 12; this indicates that rPfGR is a homodimeric enzyme. As detailed in Section 2, the quantitation of rPfGR was based on the molar absorbance of the £avoenzyme in the E ox form at 461 nm ( Table 2 ). The absorption spectra of rPfGR in the oxidized form E ox and the 2-electron reduced form EH P (Fig. 1) exhibit the typical characteristics of the pyridine nucleotidedisul¢de oxidoreductase family [6] . Table 2 also includes data on the £uorescence of the £avin and the unique tryptophan residue of PfGR. These £uorescence properties can be used for monitoring changes in the protein induced by ligand binding and by mutations [24] .
Inhibition of PfGR by methylene blue
When 10 WM methylene blue was present in the assay mixture the activity of rPfGR was 60% lower than in the control assay. This inhibition did not show any time dependence and was completely reversible by dilution. Also, preincubation of rPfGR at 2 U/ml (= 0.17 WM) with up to 500 WM methylene blue^in the absence or presence of 100 WM NADPH, at pH 6.9 or pH 7.4^did not lead to irreversible inactivation. Other inhibitors such as carmustine are known to modify the NADPH reduced enzyme irreversibly [25] .
The K m -values for the substrates NADPH and GSSG were found to be unchanged in the presence of methylene blue. Assuming non-competitive inhibition, the K i -values of methylene blue were 6.4 ( þ 0.3) WM for the parasite enzyme and 16.1 ( þ 0.8) WM for human GR (Fig. 2) .
Methylene blue is an approved drug. Common indications are septic shock [26] ^methylene blue appears to inhibit enzymes of NO metabolism [27] ^and certain forms of methemoglobinemia [28] . Against malaria it has been used only on sporadic occasions [15, 16] . At the therapeutic blood concentration of approximately 50 WM, a number of other molecular targets in P. falciparum such as the heme-polymerization reaction [29] might be a¡ected. Glutathione reductase is the ¢rst molecule to be identi¢ed as a target of methylene blue in the parasite. Taking into account the speci¢c accumulation of methylene blue in the parasites [16, 30] , the inhibition of PfGR (Fig. 2) is likely to contribute signi¢cantly to the cytotoxic e¡ects. Consequently the phenothiazine structure of methylene blue [16] will be included in the lead compounds for the rational development of therapeutic GR inhibitors [4, 11, 31] . Work on the crystallization of the GR-methylene blue complexes is in progress. Under the conditions used for analyzing human GR crystals by X-ray di¡raction (0.9 M ammonium sulfate in assay bu¡er), the apparent K i -value of PfGR for methylene blue was found to be 23 WM while the K m -values for NADPH and GSSG increased to about 100 WM. This suggests that the structures of catalytically competent PfGR as well as methylene blue-inhibited PfGR can be Fig. 1 . Absorption spectra of PfGR. The measurements were conducted under anaerobic conditions with 9.6 WM enzyme in 50 mM potassium phosphate, 2 mM EDTA, pH 7.45 at 25³C [21] . The solid line represents E ox , the yellow oxidized enzyme species, and the dotted line EH P , the 2-electron reduced orange-colored enzyme species which was obtained from E ox using sodium borohydride. The spectra of E ox and EH P at pH 6.9 in 50 mM phosphate-2 mM EDTA bu¡er show the same characteristics as at pH 7.45 (data not shown). EH P , possibly complexed with NADPH and carrying glutathione as a mixed disul¢de [33] is the predominant form of glutathione reductase in vivo [7] . Apart from the K i for methylene blue, the data for human GR were taken from [7,10^12] . Recombinant PfGR was found not to di¡er in its enzymic properties from the authentic enzyme. The somewhat lower K m -values, namely 4.8 WM for NADPH and 69 WM for GSSG reported previously for authentic PfGR [13] , could not be reproduced in the present study where more enzyme puri¢ed from P. falciparum was available for kinetic studies.
studied by crystallographic methods [10, 11] . It will be interesting to see if the drug binds in the intersubunit cavity [10] as it is the case for most known tricyclic inhibitors of human GR [11, 31, 32] . When modelling the amino acid sequence of PfGR [14] into the structure of human GR [10] , only 32% identity was found for the residues lining this cavity. In conclusion, structural comparisons of PfGR with human GR, particularly those distinctions responsible for the di¡erent inhibition by methylene blue, are expected to serve as an approach to the development of selective drugs. 
